Skip to main content
DU

Dunad Therapeutics

London, United Kingdom
Last funding
$24.0M
Series ANov 2021

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.

Backed byEpidarex CapitalNovartisBioGeneration Ventures

About Dunad Therapeutics

How much funding has Dunad Therapeutics raised?

Dunad Therapeutics has raised $24.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are Dunad Therapeutics's investors?

Dunad Therapeutics's investors include Epidarex Capital, Novartis, BioGeneration Ventures.

Where is Dunad Therapeutics headquartered?

Dunad Therapeutics is headquartered in London, United Kingdom.

What does Dunad Therapeutics do?

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.

What stage is Dunad Therapeutics at?

Dunad Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dunad Therapeutics — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/dunad-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2021). Dunad Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/dunad-therapeutics
Wikipedia (cite web)
{{cite web |title=Dunad Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dunad-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Dunad Therapeutics? Request a listing update

Founder contacts
m***@dunad.co.uk
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →